MedPath

comparative study to see which drug, hyperbaric levobupivacaine or Hyperbaric Ropivacaine, to give better anesthesia.

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/02/063088
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) patients for lower abdominal surgeries

2) patients for lower limb surgeries

Exclusion Criteria

1) pregnancy

2) allergy to local anesthetics

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the characteristics of subarachnoid block induced by hyperbaric Inj. Levobupivacaine <br/ ><br>0.5% with fentanyl and hyperbaric ropivacaine 0.75% with fentanyl in lower abdominal and lower <br/ ><br>extremity surgerieTimepoint: motor block is assesed at 5 ,10, 15 and 20 minutes and sensory <br/ ><br>block at 5, 10 , 15, 20, 30, 45, 60, 90 and 120 minutes
Secondary Outcome Measures
NameTimeMethod
To compare the hemodynamic changes & side effectsTimepoint: motor block is assesed at 5 ,10, 15 & 20 minutes & sensory <br/ ><br>block at 5, 10 , 15, 20, 30, 45, 60, 90 & 120 minutes
© Copyright 2025. All Rights Reserved by MedPath